Malgorzata Kowal

20-081 Lublin 11 Staszica St
Lublin, LU 20081, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Serum Levels of Human Neutrophil Peptides 1-3 (HNP1-3) as Potential Biomarkers in Psoriasis and Associated Comorbidities.

Serum Levels of Human Neutrophil Peptides 1-3 (HNP1-3) as Potential Biomarkers in Psoriasis and Associated Comorbidities.

Journal: Biomedicines

Published: May 27, 2025

The Expression of Activation Markers CD25 and CD69 Increases during Biologic Treatment of Psoriasis.

The Expression of Activation Markers CD25 and CD69 Increases during Biologic Treatment of Psoriasis.

Journal: Journal of clinical medicine

Published: September 17, 2023

Selected miRNA and Psoriasis-Cardiovascular Disease (CVD)-Overweight/Obesity Network-A Pilot Study.

Selected miRNA and Psoriasis-Cardiovascular Disease (CVD)-Overweight/Obesity Network-A Pilot Study.

Journal: International journal of molecular sciences

Published: August 03, 2023

Multiple Cytokine Analysis of Th1/Th2/Th9/Th17/Th22/Treg Cytokine Pathway for Individual Immune Profile Assessment in Patients with Psoriasis.

Multiple Cytokine Analysis of Th1/Th2/Th9/Th17/Th22/Treg Cytokine Pathway for Individual Immune Profile Assessment in Patients with Psoriasis.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: November 24, 2022

Serum Levels of Selected IL-1 Family Cytokines in Patients with Morphea.

Serum Levels of Selected IL-1 Family Cytokines in Patients with Morphea.

Journal: Journal of clinical medicine

Published: August 29, 2022

Preliminary observations on ANGPT1 and ANGPT2 polymorphisms in systemic sclerosis: ANGPT2 rs2442598 and rs3739390 are associated with disease susceptibility and diffuse disease subtype.

Preliminary observations on ANGPT1 and ANGPT2 polymorphisms in systemic sclerosis: ANGPT2 rs2442598 and rs3739390 are associated with disease susceptibility and diffuse disease subtype.

Journal: Polish archives of internal medicine

Published: October 13, 2021

The Genetic Variants of NOTCH3 (6746T>C) and PSMA6 (-8C>G) as Possible Risk Factors of Psoriasis Development.

The Genetic Variants of NOTCH3 (6746T>C) and PSMA6 (-8C>G) as Possible Risk Factors of Psoriasis Development.

Journal: Life (Basel, Switzerland)

Published: July 22, 2021

Assessment of Selected Matrix Metalloproteinases (MMPs) and Correlation with Cytokines in Psoriatic Patients.

Assessment of Selected Matrix Metalloproteinases (MMPs) and Correlation with Cytokines in Psoriatic Patients.

Journal: Mediators of inflammation

Published: March 04, 2021

Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple Myeloma.

Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple Myeloma.

Journal: Cells

Published: December 29, 2020

Osteopontin Serum Concentration and Metabolic Syndrome in Male Psoriatic Patients.

Osteopontin Serum Concentration and Metabolic Syndrome in Male Psoriatic Patients.

Journal: Journal of clinical medicine

Published: December 14, 2020

Circulating miRNA-181b-5p, miRNA-223-3p, miRNA-210-3p, let 7i-5p, miRNA-21-5p and miRNA-29a-3p in patients with localized scleroderma as potential biomarkers.

Circulating miRNA-181b-5p, miRNA-223-3p, miRNA-210-3p, let 7i-5p, miRNA-21-5p and miRNA-29a-3p in patients with localized scleroderma as potential biomarkers.

Journal: Scientific reports

Published: May 21, 2020

IL-17A in the Psoriatic Patients' Serum and Plaque Scales as Potential Marker of the Diseases Severity and Obesity.

IL-17A in the Psoriatic Patients' Serum and Plaque Scales as Potential Marker of the Diseases Severity and Obesity.

Journal: Mediators of inflammation

Published: March 02, 2020

Showing 1-12 of 38

Last Updated: 09/26/2026